Cacem, Portugal

Emilia Leitao

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Hovione Inter Limited. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Emilia Leitao. Retrieved from https://idiyas.com/inventor/emilia-leitao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Emilia Leitao: A Trailblazer in Steroidal Phosphate Compound Innovations

Introduction: Emilia Leitao, an accomplished inventor from Cacem, Portugal, has made significant contributions to the field of chemical engineering. With a notable focus on steroidal phosphate compounds, her innovative approach has led to advancements in pharmaceutical applications.

Latest Patents: Emilia holds a patent for a "Process for obtaining steroidal phosphate compounds." This patent outlines a method for producing 21-disodium phosphate pregnane derivative compounds of a specific formula, utilizing spray drying technology to enhance efficiency and effectiveness in the manufacturing process.

Career Highlights: Emilia is currently affiliated with Hovione Inter Limited, where she plays a critical role in research and development. Her dedication to her work has positioned her as a key figure in the company, contributing to its reputation for excellence in pharmaceutical manufacturing.

Collaborations: In her professional journey, Emilia has collaborated with esteemed colleagues such as Luis Sobral and Filipe Gaspar. These partnerships have fostered a dynamic work environment that encourages innovation and the sharing of ideas.

Conclusion: Emilia Leitao is a prominent inventor whose work in steroidal phosphate compounds has paved the way for new possibilities in the pharmaceutical industry. Her commitment to innovation and collaboration continues to inspire fellow researchers and inventors alike.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…